Most of us know oncotarget as a global, peer-reviewed journal whose popularity has continued to rise. The reviewers primarily focus their endeavors on all cancer types. Lately, oncotarget’s reputation has grown significantly due to their influence. They have been doing several peer-reviews that are not only constructive but also insightful and punctual. Such information helps the researchers a lot in recommending treatment protocols to employ in improving management of cancer patients. At the same time, the journal addresses the effect of managing programs as well as new relaxing agents to enhance the quality of life. As well, the journal extensively explores the proof of new and existing treatments, so as to improve the outcomes with ease. Oncotarget is published by Impact Journals
Some of the Basics Addressed by Cancer Researchers
So far, the first prescription for cancer is chemo and radiotherapies, which most people struggle with. For some severe cancer cases like pancreatic, the forecast happens to be grimmer. According to the information published on Oncotarget, some proteins have been discovered, which could be used for eradication of the duplicating cancer cells. They are still on the ground to ensure that the mechanism they discovered unleashes during mitosis. Should that succeed, it will be suitable for the treatment of aggressive cancer cases that are not instigated by traditional chemo.
According to the specialists, during the mitosis of cancer cells, they discovered a particular mechanism beset by Phenanthridine derivatives that they tested. Either way, they are working towards finding a way through which they catalyze the proliferation of cancer cells. When they are proliferated speedily, they tend to die even faster. Identification of the mechanism and its essence in the treatment of cancer opens an alleyway for the eradication of the rapidly developing tumors, without causing damage to the body tissues.
It is fortunate that health specialists are working behind the scenes to discover effective ways of killing cancer cells. Mikhail is also a renowned specialist with a particular interest in the cancer initiative. He is known for his prowess in research as well as editing the oncotargets. In his endeavors, Mikhail seeks to find permanent solutions for the life-threatening condition. They are a power-packed team ready to pursue their goals to the end.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/